| Phase 4 |
| NCT07609940 |
Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of… |
Relapsed/Refractory Multiple Myeloma (RRMM) |
Not Yet Recruiting |
| Phase 3 |
| NCT05730036 |
A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab… |
Relapsed Refractory Multiple Myeloma (RRMM) |
Recruiting |
| NCT06932562 |
A Study to Learn How Safe and How Well Linvoseltamab Works Compared to Standard Treatment… |
Multiple Myeloma |
Recruiting |
| NCT07222761 |
A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination… |
Relapsed and/or Refractory Multiple Myeloma (RRMM) |
Recruiting |
| NCT07393282 |
A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering… |
High Risk Smoldering Multiple Myeloma (HR-SMM) |
Recruiting |
| NCT07624513 |
Determination 2 - Isatuximab, Iberdomide, Bortezomib and Dexamethasone Induction… |
Multiple Myeloma |
Not Yet Recruiting |
| Phase 2/3 |
| NCT07428369 |
A Study of Linvo-VR vs DVRd in Transplant-Eligible Adult Participants With Newly… |
Multiple Myeloma (MM) |
Not Yet Recruiting |
| Phase 2 |
| NCT06910124 |
Linvoseltamab in Addition to Lenalidomide (L2) During Maintenance Therapy of NDMM to… |
Multiple Myeloma |
Recruiting |
| NCT06140524 |
A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma… |
Monoclonal Gammopathy of Undetermined Significance (MGUS) |
Recruiting |
| NCT05955508 |
A Proof-of-Concept Trial to Study the Safety and Activity of Linvoseltamab in Adult… |
Smoldering Multiple Myeloma (SMM) |
Active, Not Recruiting |
| NCT07009899 |
BCMA Bispecific Antibody Therapy for Post-BCMA CAR T-Cell Therapy Relapse (RECLAIM) |
Multiple Myeloma |
Not Yet Recruiting |
| Phase 1/2 |
| NCT07181941 |
Response-Based Dose Reduction of Linvoseltamab in the Treatment of Relapsed, Refractory… |
Recurrent Multiple Myeloma |
Recruiting |
| NCT06669247 |
A Study to Assess the Safety and Anti-Tumor Activity of REGN7945 in Combination With… |
Relapsed/Refractory Multiple Myeloma |
Recruiting |
| NCT07455851 |
A Trial to Study if REGN17372 in Combination With Linvoseltamab is Tolerable for Adult… |
Relapsed Refractory Multiple Myeloma (RRMM) |
Recruiting |
| NCT03761108 |
Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple… |
Multiple Myeloma |
Recruiting |
| NCT06292780 |
A Trial to Learn if Linvoseltamab is Safe and Works in Adults With Relapsed or Refractory… |
Relapsed/Refractory Systemic Light Chain Amyloidosis |
Recruiting |
| NCT05828511 |
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and… |
Multiple Myeloma |
Recruiting |
| Phase 1 |
| NCT05137054 |
A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other… |
Multiple Myeloma |
Recruiting |
| NCT06369467 |
Short-Term Linvoseltamab Treatment on Top of Chronic Dupilumab Treatment for Adults With… |
Food Allergy |
Recruiting |